Mark C Houston

Summary

Publications

  1. ncbi request reprint Nutraceuticals, vitamins, antioxidants, and minerals in the prevention and treatment of hypertension
    Mark C Houston
    Department of Medicine, Division of General Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA
    Prog Cardiovasc Dis 47:396-449. 2005
  2. ncbi request reprint The role of mercury and cadmium heavy metals in vascular disease, hypertension, coronary heart disease, and myocardial infarction
    Mark C Houston
    Vanderbilt University School of Medicine, USA
    Altern Ther Health Med 13:S128-33. 2007
  3. ncbi request reprint The role of nutrition, nutraceuticals, vitamins, antioxidants, and minerals in the prevention and treatment of hypertension
    Mark C Houston
    Vanderbilt University School of Medicine
    Altern Ther Health Med 19:32-49. 2013
  4. doi request reprint The importance of potassium in managing hypertension
    Mark C Houston
    Hypertension Institute, Saint Thomas Medical Plaza, Nashville, TN 37205, USA
    Curr Hypertens Rep 13:309-17. 2011
  5. doi request reprint Nutrition and nutraceutical supplements in the treatment of hypertension
    Mark C Houston
    Vanderbilt University School of Medicine, Hypertension Institute, Saint Thomas Medical Group, 4230 Harding Road, Suite 400, Medical Plaza Building, Nashville, TN 37205, USA
    Expert Rev Cardiovasc Ther 8:821-33. 2010
  6. ncbi request reprint Potassium, magnesium, and calcium: their role in both the cause and treatment of hypertension
    Mark C Houston
    Vanderbilt University School of Medicine, Nashville, TN 37205, USA
    J Clin Hypertens (Greenwich) 10:3-11. 2008
  7. ncbi request reprint Treatment of hypertension with nutraceuticals, vitamins, antioxidants and minerals
    Mark C Houston
    Vanderbilt University School of Medicine, Nashville, TN 37205, USA
    Expert Rev Cardiovasc Ther 5:681-91. 2007
  8. doi request reprint The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease
    Mark C Houston
    Hypertension Institute, 4230 Harding Road, Suite 400, Nashville, TN 37205, USA
    Ther Adv Cardiovasc Dis 4:165-83. 2010
  9. doi request reprint Role of mercury toxicity in hypertension, cardiovascular disease, and stroke
    Mark C Houston
    Department of Medicine, Vanderbilt University School of Medicine, Division of Human Nutrition, Saint Thomas Medical Group, Saint Thomas Hospital, Nashville, TN, USA
    J Clin Hypertens (Greenwich) 13:621-7. 2011
  10. ncbi request reprint Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States
    Mark C Houston
    Consortium for Southeastern Hypertension Control COSEHC and Vanderbilt University School of Medicine and St Thomas Hospital, Nashville, Tennessee, USA
    Am J Med Sci 329:276-91. 2005

Detail Information

Publications14

  1. ncbi request reprint Nutraceuticals, vitamins, antioxidants, and minerals in the prevention and treatment of hypertension
    Mark C Houston
    Department of Medicine, Division of General Internal Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA
    Prog Cardiovasc Dis 47:396-449. 2005
    ....
  2. ncbi request reprint The role of mercury and cadmium heavy metals in vascular disease, hypertension, coronary heart disease, and myocardial infarction
    Mark C Houston
    Vanderbilt University School of Medicine, USA
    Altern Ther Health Med 13:S128-33. 2007
    ..Specific testing for acute and chronic toxicity and total body burden using hair, toenail, urine, serum, etc. with baseline and provoked evaluation should be done...
  3. ncbi request reprint The role of nutrition, nutraceuticals, vitamins, antioxidants, and minerals in the prevention and treatment of hypertension
    Mark C Houston
    Vanderbilt University School of Medicine
    Altern Ther Health Med 19:32-49. 2013
    ..It is the purpose of this article to review only the hypertension clinical trials that have evaluated the clinical use and efficacy of nutrition, weight loss, exercise, and nutritional supplements, vitamins, minerals, and antioxidants...
  4. doi request reprint The importance of potassium in managing hypertension
    Mark C Houston
    Hypertension Institute, Saint Thomas Medical Plaza, Nashville, TN 37205, USA
    Curr Hypertens Rep 13:309-17. 2011
    ..Increasing consumption of potassium to 4.7 g per day predicts lower event rates for future cardiovascular disease, with estimated decreases of 8% to 15% in CVA and 6% to 11% in myocardial infarction...
  5. doi request reprint Nutrition and nutraceutical supplements in the treatment of hypertension
    Mark C Houston
    Vanderbilt University School of Medicine, Hypertension Institute, Saint Thomas Medical Group, 4230 Harding Road, Suite 400, Medical Plaza Building, Nashville, TN 37205, USA
    Expert Rev Cardiovasc Ther 8:821-33. 2010
    ..The expanded scientific roles for nutraceutical supplements will be discussed in relation to the prevention and treatment of essential hypertension and cardiovascular diseases...
  6. ncbi request reprint Potassium, magnesium, and calcium: their role in both the cause and treatment of hypertension
    Mark C Houston
    Vanderbilt University School of Medicine, Nashville, TN 37205, USA
    J Clin Hypertens (Greenwich) 10:3-11. 2008
    ..A high intake of these minerals through increased consumption of fruits and vegetables may improve blood pressure levels and reduce coronary heart disease and stroke...
  7. ncbi request reprint Treatment of hypertension with nutraceuticals, vitamins, antioxidants and minerals
    Mark C Houston
    Vanderbilt University School of Medicine, Nashville, TN 37205, USA
    Expert Rev Cardiovasc Ther 5:681-91. 2007
    ....
  8. doi request reprint The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease
    Mark C Houston
    Hypertension Institute, 4230 Harding Road, Suite 400, Nashville, TN 37205, USA
    Ther Adv Cardiovasc Dis 4:165-83. 2010
    ..It is beyond the scope of this paper to review these trials. The reader is referred to the vast literature on this subject...
  9. doi request reprint Role of mercury toxicity in hypertension, cardiovascular disease, and stroke
    Mark C Houston
    Department of Medicine, Vanderbilt University School of Medicine, Division of Human Nutrition, Saint Thomas Medical Group, Saint Thomas Hospital, Nashville, TN, USA
    J Clin Hypertens (Greenwich) 13:621-7. 2011
    ..Specific testing for acute and chronic toxicity and total body burden using hair, toenail, urine, and serum should be performed...
  10. ncbi request reprint Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States
    Mark C Houston
    Consortium for Southeastern Hypertension Control COSEHC and Vanderbilt University School of Medicine and St Thomas Hospital, Nashville, Tennessee, USA
    Am J Med Sci 329:276-91. 2005
    ....
  11. ncbi request reprint Is population-wide diuretic use directly associated with the incidence of end-stage renal disease in the United States? A hypothesis
    Ralph G Hawkins
    Hypertension Institute, St Thomas Hospital, Nashville, Tennessee, USA
    Am J Hypertens 18:744-9. 2005
    ..We introduce the hypothesis that population-wide use of diuretics might be associated with acceleration of the incidence of end-stage renal disease (ESRD)...
  12. ncbi request reprint Efficacy and safety of coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia: results of the AVALON trial
    Franz H Messerli
    St Luke s Roosevelt Hospital Center, New York, NY 10019, USA
    J Clin Hypertens (Greenwich) 8:571-81; quiz 582-3. 2006
    ..Concomitant administration of amlodipine and atorvastatin is an effective and well tolerated treatment for coexisting hypertension and dyslipidemia...
  13. ncbi request reprint Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II: treatment recommendations for management of the global cardiovascular risk of hypertension,
    William Bestermann
    Consortium for Southeastern Hypertension Control, Beaufort, South Carolina, USA
    Am J Med Sci 329:292-305. 2005
    ..A statin should be used initially for hyperlipidemia unless contraindicated. Combinations of antihypertensive, antiglycemic, and lipid-lowering agents will often be required...
  14. ncbi request reprint ALLHAT debate: diuretics are not preferred, first-line initial therapy for hypertension
    Mark C Houston
    Arch Intern Med 164:570-1; author reply 571-2. 2004